Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?

Carlotta GiupponiDiego BertoliErika BorlenghiChiara CattaneoTatiana ZollnerLorenzo MasinaSamuele BagnascoElisa CerquiFrancesca FedericoChiara PaganiSilvana ArchettiDuilio BrugnoniGiuseppe RossiAlessandra Tucci

Published in: Blood cancer journal (2023)

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
risk assessment
low grade
disease activity
free survival
ulcerative colitis
dendritic cells
systemic lupus erythematosus
immune response
high grade